Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Status:
Recruiting

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.

Phase 3

Vanda Pharmaceuticals